Prothena Corp. plc Stock
Prothena Corp. plc Stock
There is an upward development for Prothena Corp. plc compared to yesterday, with an increase of €0.40 (2.080%).
With 12 Buy predictions and not the single Sell prediction the community is currently very high on Prothena Corp. plc.
With a target price of 81 € there is potential for a 315.38% increase which would mean more than doubling the current price of 19.5 € for Prothena Corp. plc.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Prothena Corp. plc | 2.080% | 1.563% | -12.946% | -59.711% | -43.966% | -12.162% | - |
Ardelyx Inc. | 5.440% | 7.123% | -7.526% | 58.693% | 9.273% | 3.541% | - |
Salarius Pharmaceuticals Inc. | -2.830% | -5.069% | 5.641% | -71.389% | -25.766% | -98.474% | -99.994% |
Brainstorm Cell | 5.560% | -26.131% | -44.654% | -86.685% | 58.405% | -87.328% | - |
Comments
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $98.00 to $80.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat